esophageal cancer Mar 29, 2022 Lucid Diagnostics Reports $300K in Preliminary Q4 Revenues Mar 3, 2022 Lucid Diagnostics Acquires Laboratory Assets From ResearchDx for $6.2M Mar 2, 2022 Castle Bio Adds Data for DecisionDx Melanoma Assay, Eyes Squamous Cell Carcinoma Reimbursement Premium Feb 28, 2022 Castle Biosciences Q4 Revenues Grow 45 Percent Nov 17, 2021 Newly Public Lucid Diagnostics Posts $200K in Preliminary Q3 Revenues Nov 8, 2021 BTIG, Canaccord Genuity Initiate Coverage of Lucid Diagnostics With Buy Ratings Oct 27, 2021 Castle Biosciences Buy of Cernostics Aligns With Goal to Diversify Portfolio Premium Oct 21, 2021 Agilent Obtains CE Mark for CDx to Guide Treatment With Immunotherapeutic Agent Opdivo Oct 19, 2021 Castle Biosciences Acquires Cernostics for up to $80M Oct 14, 2021 Lucid Diagnostics Prices $70M IPO, Starts Trading on Nasdaq Jun 10, 2021 Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test May 26, 2021 Lucid Diagnostics Gets CE Mark for Esophageal Cell Collection Device Oct 12, 2020 Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Sep 10, 2020 Cernostics, Deciphex to Collaborate on AI-Based Histology in Barrett's Esophagus Aug 6, 2020 PavMed Raises $7M in Private Funding Round Jul 1, 2020 AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection Apr 8, 2020 Esophageal Cancer Case Study Suggests Utility as Clinicians Explore Expanded Uses for Liquid Biopsy Mar 2, 2020 Lucid Diagnostics Aims to Improve Esophageal Cancer Screening With New Device, Assay Premium Feb 25, 2020 Capsulomics, Johns Hopkins Partner on Esophageal Cancer, Barrett's Esophagus Research Load More Breaking News In Brief This Week: Becton Dickinson, Bionano, Yourgene, More OpGen to Raise $3.4M in Direct Stock Offering BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Careviso Closes $17.4M Series B Funding Round P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations
